We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Journal of Comparative Effectiveness Research
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Research Article

Elevated expression of histone demethylase PHF8 associates with adverse prognosis in patients of laryngeal and hypopharyngeal squamous cell carcinoma

    Gangcai Zhu

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    ,
    Lijun Liu

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Department of Otolaryngology Head & Neck Surgery, First Affiliated Hospital of South China University, Chuanshan Road 69, Hengyang, 421001, China

    ,
    Li She

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    ,
    Haolei Tan

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    ,
    Ming Wei

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    ,
    Changhan Chen

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    ,
    Zhongwu Su

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    ,
    Donghai Huang

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    ,
    Yongquan Tian

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    ,
    Yuanzheng Qiu

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    ,
    Yong Liu

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    Authors contributed equally

    Search for more papers by this author

    &
    Xin Zhang

    Department of Otolaryngology Head & Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China

    Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha 410008, Hunan, China

    Authors contributed equally

    Search for more papers by this author

    Published Online:https://doi.org/10.2217/epi.14.82

    Aim: Overexpression of histone demethylase PHF8 has been reported to function as an oncoprotein in many cancers; however, the implications of PHF8 involvement in laryngeal and hypopharyngeal squamous cell carcinoma (LHSCC) remain unclear. This study aims to explore the expression of PHF8 and its clinical significance in LHSCC. Materials & methods: Western blotting and immunohistochemistry were performed to evaluate PHF8 protein expression in fresh and archived LHSCC samples. Global expressions of H3K27 and H3K9 methylation were analyzed in a cell line with PHF8 siRNA treatment. Results & conclusion: In our study, PHF8 was upregulated in fresh LHSCC tissues. Immunohistochemical staining revealed that the expression of PHF8 was positively associated with T classification, clinical stage, primary tumor position and tumor relapse. Survival analysis demonstrated that high PHF8 expression was significantly associated with shorter overall survival and disease-free survival. Moreover, PHF8 regulates the levels of H3K9me2 and H3K27me2 in LHSCC. Taken together, PHF8 might be a novel prognostic marker for this disease.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1 Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 64(1), 9–29 (2014).Crossref, MedlineGoogle Scholar
    • 2 Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int. J. Cancer 97(1), 72–81 (2002).Crossref, Medline, CASGoogle Scholar
    • 3 Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 371(9625), 1695–1709 (2008).Crossref, Medline, CASGoogle Scholar
    • 4 Sturgis EM. The International Head and Neck Cancer Epidemiology Consortium. Head Neck 33(1), 141 (2011).Crossref, MedlineGoogle Scholar
    • 5 Elsheikh MN, Rinaldo A, Hamakawa H et al. Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma. Head Neck 28(9), 842–849 (2006).Crossref, MedlineGoogle Scholar
    • 6 Russo N, Wang X, Liu M et al. A novel approach to biomarker discovery in head and neck cancer using an autoantibody signature. Oncogene 32(42), 5026–5037 (2013).Crossref, Medline, CASGoogle Scholar
    • 7 Rozov SM, Berdnikov VA, Gorel FL, Lavrent'eva MV, Solonenko LP. [Structural characteristics of lysine-rich histone from the sperm of a mollusk Anodonta piscinalis]. Mol. Biol. (Mosk.) 18(6), 1497–1508 (1984).Medline, CASGoogle Scholar
    • 8 Cheng CS, Rai K, Garber M et al. Semiconductor-based DNA sequencing of histone modification states. Nat. Commun. 4, 2672 (2013).Crossref, MedlineGoogle Scholar
    • 9 Fischle W. Molecular mechanisms of histone modification function. Biochim. Biophys. Acta 1839(8), 621–622 (2014).Crossref, Medline, CASGoogle Scholar
    • 10 Zhang Y, Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15(18), 2343–2360 (2001).Crossref, Medline, CASGoogle Scholar
    • 11 Bannister AJ, Kouzarides T. Reversing histone methylation. Nature 436(7054), 1103–1106 (2005).Crossref, Medline, CASGoogle Scholar
    • 12 Carr SM, Munro S, Zalmas LP et al. Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor. Proc. Natl Acad. Sci. USA 111(31), 11341–11346 (2014).Crossref, Medline, CASGoogle Scholar
    • 13 Barski A, Cuddapah S, Cui KR et al. High-resolution profiling of histone methylations in the human genome. Cell 129(4), 823–837 (2007).Crossref, Medline, CASGoogle Scholar
    • 14 Bannister AJ, Zegerman P, Partridge JF et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410(6824), 120–124 (2001).Crossref, Medline, CASGoogle Scholar
    • 15 Lachner M, O'Carroll N, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410(6824), 116–120 (2001).Crossref, Medline, CASGoogle Scholar
    • 16 Czermin B, Melfi R, Mccabe D, Seitz V, Imhof A, Pirrotta V. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites. Cell 111(2), 185–196 (2002).Crossref, Medline, CASGoogle Scholar
    • 17 Yamane K, Tateishi K, Klose RJ et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell 25(6), 801–812 Crossref, MedlineGoogle Scholar
    • 18 Liu G, Bollig-Fischer A, Kreike B et al. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene 28(50), 4491–4500 (2009).Crossref, Medline, CASGoogle Scholar
    • 19 Biron VL, Mohamed A, Hendzel MJ, Underhill DA, Seikaly H. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas. J. Otolaryngol. Head N. 41, S65–S70 (2012).MedlineGoogle Scholar
    • 20 Gannon OM, De Long LM, Endo-Munoz L, Hazar-Rethinam M, Saunders NA. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation. Clin. Cancer Res. 19(2), 428–441 (2013).Crossref, Medline, CASGoogle Scholar
    • 21 Bragado P, Estrada Y, Sosa MS et al. Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties. PLoS ONE 7(1), e29974 (2012).Crossref, Medline, CASGoogle Scholar
    • 22 Laytragoon-Lewin N, Castro J, Elmberger G et al. DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients – new diagnostic approaches and treatment. Eur. J. Cancer 47, S545–S545 (2011).Crossref, MedlineGoogle Scholar
    • 23 Feng WJ, Yonezawa M, Ye J, Jenuwein T, Grummt I. PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1/2 demethylation. Nat. Struct. Mol. Biol. 17(4), 445–450 (2010).•• Reveals a functional interplay between H3K4 methylation and H3K9me1/2 demethylation by PHF8, which links dynamic histone methylation to rDNA transcription and neural disease.Crossref, Medline, CASGoogle Scholar
    • 24 Yu L, Wang Y, Huang S et al. Structural insights into a novel histone demethylase PHF8. Cell Res. 20(2), 166–173 (2010).•• Sheds light on the molecular mechanism underlying PHF8-associated developmental and neurological diseases.Crossref, Medline, CASGoogle Scholar
    • 25 Qi HH, Sarkissian M, Hu GQ et al. Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature 466(7305), 503–507 (2010).Crossref, Medline, CASGoogle Scholar
    • 26 Pasini D, Hansen KH, Christensen J, Agger K, Cloos PaC, Helin K. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and polycomb-repressive complex 2. Genes Dev. 22(10), 1345–1355 (2008).Crossref, Medline, CASGoogle Scholar
    • 27 Shen YZ, Pan XF, Zhao H. The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer. Biochem. Biophys. Res. Commun. 451(1), 119–125 (2014).Crossref, Medline, CASGoogle Scholar
    • 28 Bjorkman M, Ostling P, Harma V et al. Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion. Oncogene 31(29), 3444–3456 (2012).• First discovery that PHF8 is activated in a subset of prostate cancers and promotes cancer progression.Crossref, Medline, CASGoogle Scholar
    • 29 Sun XJ, Qiu JJ, Zhu ST et al. Oncogenic features of PHF8 histone demethylase in esophageal squamous cell carcinoma. PLoS ONE 8(10), e77353 (2013).Crossref, Medline, CASGoogle Scholar
    • 30 Lim HJ, Dimova NV, Tan MK, Sigoillot FD, King RW, Shi Y. The G2/M regulator histone demethylase PHF8 is targeted for degradation by the anaphase-promoting complex containing CDC20. Mol. Cell. Biol. 33(21), 4166–4180 (2013).Crossref, Medline, CASGoogle Scholar
    • 31 Wang J, Lin XQ, Wang S et al. PHF8 and REST/NRSF co-occupy gene promoters to regulate proximal gene expression. Sci. Rep. 4, 5008 (2014).Crossref, Medline, CASGoogle Scholar
    • 32 Asensio-Juan E, Gallego C, Martinez-Balbas MA. The histone demethylase PHF8 is essential for cytoskeleton dynamics. Nucleic Acids Res. 40(19), 9429–9440 (2012).Crossref, Medline, CASGoogle Scholar
    • 33 Liu Y, Xie CL, Zhang X et al. Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance. Eur. J. Cancer 46(16), 3007–3015 (2010).Crossref, Medline, CASGoogle Scholar
    • 34 Zhu G, Cai G, Liu Y et al. Quantitative iTRAQ LC-MS/MS proteomics reveals transcription factor crosstalk and regulatory networks in hypopharyngeal squamous cell carcinoma. J. Cancer 5(7), 525–536 (2014).Crossref, Medline, CASGoogle Scholar
    • 35 Filleron T, Laplanche A, Boher JM, Kramar A. An R function to non-parametric and piecewise analysis of competing risks survival data. Comput. Methods Programs Biomed. 100(1), 24–38 (2010).Crossref, MedlineGoogle Scholar
    • 36 R Foundation for Statistical Computing. R: a language and environment for statistical computing. www.R-project.orgGoogle Scholar
    • 37 Liu W, Tanasa B, Tyurina OV et al. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature 466(7305), 508–512 (2010).Crossref, Medline, CASGoogle Scholar
    • 38 Yatim A, Benne C, Sobhian B et al. NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol. Cell 48(3), 445–458 (2012).Crossref, Medline, CASGoogle Scholar
    • 39 Fortschegger K, De Graaf P, Outchkourov NS, Van Schaik FM, Timmers HT, Shiekhattar R. PHF8 targets histone methylation and RNA polymerase II to activate transcription. Mol. Cell. Biol. 30(13), 3286–3298 (2010).Crossref, Medline, CASGoogle Scholar
    • 40 Wysocka J, Swigut T, Xiao H et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442(7098), 86–90 (2006).Crossref, Medline, CASGoogle Scholar
    • 41 Wend P, Fang L, Zhu Q et al. Wnt/beta-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours. EMBO J. 32(14), 1977–1989 (2013).Crossref, Medline, CASGoogle Scholar
    • 42 Sundar IK, Yao H, Rahman I. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid. Redox Signal. 18(15), 1956–1971 (2013).Crossref, Medline, CASGoogle Scholar
    • 43 Johann DJ Jr, Mcguigan MD, Patel AR et al. Clinical proteomics and biomarker discovery. Ann. NY Acad. Sci. 1022, 295–305 (2004).Crossref, Medline, CASGoogle Scholar
    • 44 Masood R, Hochstim C, Cervenka B et al. A novel orthotopic mouse model of head and neck cancer and lymph node metastasis. Oncogenesis 2, e68 (2013).Crossref, Medline, CASGoogle Scholar
    • 45 Hojfeldt JW, Agger K, Helin K. Histone lysine demethylases as targets for anticancer therapy. Nat. Rev. Drug Discov. 12(12), 917–930 (2013).Crossref, Medline, CASGoogle Scholar